Related Experiment Video
Updated: Jun 28, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings
Hasya Zinger1, Yaniv Sherer, Yehuda Shoenfeld
1Department of Medicine B, Sheba Medical Center, Tel-Hashomer, Israel.
Insights
Autoimmunity plays a significant role in atherosclerosis development, beyond traditional risk factors. Understanding these immune pathways could revolutionize cardiovascular disease prevention and treatment strategies.
Area of Science:
- Cardiovascular Research
- Immunology
- Rheumatology
Background:
- Atherosclerosis is a leading cause of death globally.
- Traditional risk factors do not fully explain atherosclerosis.
- Autoimmune diseases are linked to increased cardiovascular complications.
Purpose of the Study:
- To explore the role of autoimmunity in accelerated atherosclerosis.
- To identify common pathogenic pathways in rheumatic diseases and atherosclerosis.
- To investigate potential changes in prevention and treatment strategies.
Main Methods:
- Review of existing literature on atherosclerosis and autoimmune diseases.
- Analysis of mechanisms involving autoantibodies, cytokines, and immune dysregulation.
- Correlation of cardiovascular manifestations with rheumatic conditions.
Main Results:
- Autoimmunity is a significant factor in atherosclerosis pathogenesis.
- Chronic inflammation and immune dysregulation contribute to accelerated atherosclerosis.
- Specific autoimmune diseases show increased atherosclerotic burden.
Conclusions:
- Autoimmunity is integral to atherosclerosis development, particularly in rheumatic diseases.
- Targeting immune pathways offers new avenues for cardiovascular disease management.
- Further research into shared mechanisms can improve patient outcomes.
Abstract:
Atherosclerosis is one of the major entities leading to morbidity and mortality in the western world. It is known now that atherosclerosis cannot be explained merely by the presence of the Framingham traditional risk factors and that autoimmunity takes a significant role in its pathogenesis. It is also known that individuals with autoimmune diseases demonstrate increased incidence of cardiovascular manifestations and subclinical atherosclerotic disease. The mechanisms for the assumed accelerated atherosclerosis in diseases such as systemic lupus erythematosus, rheumatoid arthritis, antiphospholipid syndrome, and systemic sclerosis include the classical risk factors, but may also be due to chronic inflammatory processes and immune dysregulation. Autoantibodies, autoantigens, pro-inflammatory cytokines, and infectious agents play a role in that process. Involvement of autoimmunity in the pathogenesis of accelerated atherosclerosis in rheumatic diseases and the common pathway that leads to this condition may lead to significant change in prevention of treatment.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Atherosclerosis III: Management

